Public Tender Offer to Shareholders of Olink Holding AB (publ)
Thermo Fisher Scientific commenced on October 31, 2023, a Tender Offer for all outstanding common shares and ADSs of Olink Holding AB (publ).
DNB Markets has been appointed Tender Agent in the Offer for Olink’s common shares (ISIN SE0015797568).
Access to this information is limited
Due to legal restrictions, access to information and documents in connection with the voluntary offer is limited. You are therefore asked to review the following information and provide the following confirmation each time you request access to offers with Offer material and acceptance options. The confirmation must be truthful and accurate .
After reading the whole text please confirm.Your confirmation must be true and accurate.
DISCLAIMER - IMPORTANT
Access to information about the offer is limited. Please read the following information and confirm.
The tender offer described on this part of the website is not being made to holders of securities in any jurisdiction in which the making of the tender offer would not be in compliance with the securities, blue sky or other laws of such jurisdiction. In those jurisdictions where applicable laws or regulations require the tender offer to be made by a licensed broker or dealer, the tender offer will be deemed to be made on behalf of Goldcup 33985 AB (u.c.t. Orion Acquisition AB) (“Buyer”), a wholly-owned subsidiary of Thermo Fisher Scientific Inc. (“Thermo Fisher”), by one or more registered brokers or dealers licensed under the laws of such jurisdiction to be designated by Buyer.
This website is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell any common shares or American Depositary Shares of Olink Holding AB (publ) (“Olink”) or any other securities, nor is it a substitute for the tender offer materials that Thermo Fisher or the Buyer has filed with the SEC by Thermo Fisher or Olink (including an offer to purchase, ADS letter of transmittal, acceptance form for common shares and certain other tender offer documents and the solicitation/recommendation statement and other documents filed with the SEC, as they may be amended from time to time, the “Tender Offer Materials”). The terms and conditions of the tender offer are published in, and the offer to purchase common shares and American Depositary Shares of Olink is made only pursuant to, the offer document and related offer materials prepared by Thermo Fisher and the Buyer and is filed with the SEC in a tender offer statement on Schedule TO. In addition, Olink has filed a solicitation/recommendation statement on Schedule 14D-9 with the SEC with respect to the tender offer.
THE TENDER OFFER MATERIALS CONTAIN IMPORTANT INFORMATION. INVESTORS AND SHAREHOLDERS OF OLINK ARE URGED TO READ THESE DOCUMENTS CAREFULLY BECAUSE THEY, AND NOT THIS DOCUMENT, GOVERN THE TERMS AND CONDITIONS OF THE TENDER OFFER, AND BECAUSE THEY CONTAIN IMPORTANT INFORMATION THAT SUCH PERSONS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR COMMON SHARES AND AMERICAN DEPOSITARY SHARES.
THE TENDER OFFER MATERIALS WILL NOT AND MAY NOT BE DISTRIBUTED, FORWARDED OR TRANSMITTED INTO OR FROM ANY JURISDICTION WHERE PROHIBITED BY APPLICABLE LAW BY ANY MEANS WHATSOEVER INCLUDING, WITHOUT LIMITATION, MAIL, FACSIMILE TRANSMISSION, E-MAIL OR TELEPHONE. THE OFFER CANNOT BE ACCEPTED BY ANY SUCH USE, MEANS OR INSTRUMENTALITY OR FROM WITHIN ANY JURISDICTION WHERE PROHIBITED BY LAW.
Please confirm that you have read and understood the disclaimer to access the information about the Tender Offer.